BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,999
$0.58
$2,899
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,999
$0.58
$2,899
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
3,490
$1.2
$4,188
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
3,490
$1.2
$4,188
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
3,490
$1.2
$4,188
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
1,510
$1.2
$1,812
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
1,510
$1.2
$1,812
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
1,510
$1.2
$1,812
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$5.88
$12,940
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,998
$0.58
$2,899
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,998
$0.58
$2,899
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,998
$5.52
$27,564
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$6.54
$45,780
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,995
$0.58
$2,897
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,995
$0.58
$2,897
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,995
$0.58
$2,897
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$6.49
$14,278
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
30,000
$3.76
$112,650
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$6.93
$34,650
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,990
$0.58
$2,894
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,990
$0.58
$2,894
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,990
$0.58
$2,894
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
30,000
$3.76
$112,650
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7.03
$7,030
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$6.91
$48,356
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,980
$0.58
$2,888
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,980
$0.58
$2,888
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,980
$0.58
$2,888
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$7.28
$16,023
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,961
$0.58
$2,877
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,961
$0.58
$2,877
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,961
$6.98
$34,638
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7.87
$7,870
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,922
$0.58
$2,855
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,922
$0.58
$2,855
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,922
$7.17
$35,276
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$7.19
$50,358
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,844
$0.58
$2,810
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1
$5,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1
$5,000
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7.34
$7,340
Showing 1150 to 1200 of 1267 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.